This procurement opportunity seeks legal assistance for the ELEGANT NORTH (EN) project, which is an EU-supported Nordic collaboration aimed at developing a new strategy for managing and sharing data on rare diseases across Denmark, Norway, and Sweden. The project will result in a generic, cross-bord
Tender closed on 16 Sept 2025. Awaiting award.
The Capital Region of Denmark is seeking bids for resource personnel in the field of soil contamination and raw materials, as detailed in the draft framework agreements (Annexes A and B of the procurement documents). The procurement is divided into two lots: Lot 1: Resource personnel for soil contam
This procurement opportunity is for the supply of orthopedic implants and related instruments specifically for hip, knee, and shoulder arthroplasties, as well as bone cement for use in these surgeries. Suppliers are invited to provide high-quality products that meet the health sector's standards and
This contract opportunity involves the supply of personal care products for all hospitals across all regions in Denmark. The buyer, Region Hovedstaden, is seeking suppliers to provide these essential products, which are crucial for patient care. The total value of the contract is approximately 102 m
This contract opportunity is for the supply of surgical sutures, clips, and ligatures. The Region Hovedstaden is seeking suppliers to provide these essential medical products as part of a re-tendering process. The total value of the contract is approximately 50.6 million DKK. Interested suppliers ca
UK-based astronomy observers can apply for travel and subsistence grants of up to £15,000 over two years to visit facilities with competitively awarded observation time.
UK biomedical researchers can apply for up to £1 million in MRC funding to purchase a single piece of mid-range capital equipment by 31 December 2027.
NERC invites qualified researchers to apply for large grants (£1.12-£3.45 million) for innovative environmental science projects lasting up to five years.
UKRI is offering up to £60 million over seven years for a director-led research institute to investigate obesity and cardiometabolic disease mechanisms with translation to prevention and treatment strategies.
